Accelmed Partners, L.P. - Jul 15, 2024 Form 4 Insider Report for STRATA Skin Sciences, Inc. (SSKN)

Role
10%+ Owner
Signature
Accelmed Partners, L.P. By: Accelmed Partners (GP), L.P., its general partner By: Accelmed Growth Partners (AGP) Ltd., its general partner By: /s/ Uri Geiger, Managing Partner
Stock symbol
SSKN
Transactions as of
Jul 15, 2024
Transactions value $
$723,999
Form type
4
Date filed
7/17/2024, 05:08 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SSKN Common Stock Purchase $724K +231K +19.04% $3.14 1.44M Jul 15, 2024 Direct
holding SSKN Common Stock 1.44M Jul 15, 2024 By: Accelmed Growth Partners (GP), L.P. F1
holding SSKN Common Stock 1.44M Jul 15, 2024 By: Accelmed Growth Partners (AGP), Ltd. F1
holding SSKN Common Stock 1.44M Jul 15, 2024 By: Accelmed Management Ltd. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held directly by Accelmed Partners, L.P. and may be deemed to be beneficially owned indirectly by (i) Accelmed Partners (GP), L.P., the general partner of Accelmed Partners, L.P., (ii) Accelmed Growth Partners (AGP) Limited, the general partner of Accelmed Partners (GP), L.P., and (iii) Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares pursuant to a management agreement. Each of Accelmed Partners (GP), L.P., Accelmed Growth Partners (AGP) Limited, and Accelmed Growth Partners Management Ltd. disclaims such beneficial ownership except to the extent of their pecuniary interest in the shares of common stock held by Accelmed Partners, L.P.